Dr. Carl A. Laskin, MD, FRCPC

Dr. Carl Laskin is an internationally-recognized expert in the specialized field of reproductive immunology and autoimmune diseases in pregnancy. As a widely-respected specialist both nationally and internationally, Dr. Laskin is well known for his clinical and research activities in the field of recurrent pregnancy loss, as well as pregnancy in women with autoimmune diseases such as systemic lupus. In 1987, he established the Treatment and Evaluation of Recurrent Miscarriage (TERM) Programme which quickly became Canada’s largest program devoted to the study and treatment of recurrent pregnancy loss. Today, along with Dr. Sony Sierra, Dr. Laskin runs the RPL program at TRIO, the largest program in Canada focused on the investigation and management of early recurrent pregnancy loss. Because of his unique and highly specialized expertise in autoimmune diseases and pregnancy, Dr. Laskin is often called upon to give opinions on some of the most complex and difficult medical cases in the field of recurrent pregnancy loss.

Dr. Laskin has been invited to present the results of his research on the role of the immune system in recurrent pregnancy loss at numerous international medical conferences in North America and Europe. His research has been published in the New England Journal of Medicine, as well as many other peer-reviewed publications.

Dr. Laskin is the Managing Director and a Founding Partner of TRIO Fertility. He is also an Associate Professor in the departments of Medicine (Rheumatology) and Obstetrics and Gynaecology (REI) at the University of Toronto; an Executive member of the Obstetric Medicine Program, University of Toronto; and a Past President of the Canadian Fertility & Andrology Society (CFAS). He remains actively involved in this organization. In 2022, Dr. Laskin received the prestigious CFAS Award of Excellence for his outstanding contribution to and leadership in the field of Reproductive Medicine and Science.